Quick Read – Dislocation between share price and product progress is exactly the kind of setup retail investors should scan for. – Here are seven healthcare AI stocks trading under $50 where the bull case is grounded, not hype. – The analyst who called NVIDIA in 2010 just named…
s top 10 stocks and AbCellera Biologics wasn’t one of them. Get them here FREE
Healthcare AI stocks have been hammered in 2026, with several names down 30% to 65% year to date even as their underlying platforms keep maturing. That dislocation between share price and product progress is exactly the kind of setup retail investors should scan for: real revenue, real partnerships, and prices low enough that a successful multi-year execution path can plausibly deliver triple-digit returns. The $50 ceiling is the filter; the AI flywheel is the thesis.
With that in mind, here are seven healthcare AI stocks trading under $50 where the bull case is grounded in product, partnership, or platform data, not hype. Tempus AI Tempus AI (NASDAQ: TEM) pairs genomic diagnostics with a massive healthcare data library that pharma partners license for AI-driven drug discovery. At around $43.93, shares are down 25.6% year to date and are well below the $67.20 analyst target price, with 10 Buy or Strong Buy ratings against one Sell.